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ABSTRACT
Staphylococcus epidermidis is an important cause of catheter-associated infections, which are attributed to
its ability to form a multilayered biofilm on polymeric surfaces. This ability depends, in part, on the
activity of the icaADBC locus and the icaR gene, which are involved in the production of the
polysaccharide intercellular adhesin (PIA) that is functionally necessary for cell-to-cell adhesion and
biofilm accumulation. The present study determined: (1) the prevalence of the icaADBC operon in
S. epidermidis isolates from catheter-related and other nosocomial infections; (2) the correlation between
the presence of this operon, biofilm production and resistance to antibiotics; (3) the expression of ica
genes and biofilm production; and (4) the genetic relatedness of the isolates. The results showed that
icaRADBC was present in 45% of the isolates included in the study, and that such isolates were
significantly more resistant to the main antibiotics tested than were ica-negative isolates. The presence of
the entire cluster did not always correlate with biofilm production, determined under different culture
conditions, but there was evidence to suggest a correlation when at least two genes (icaAD) were
co-transcribed. Eight of 18 ica-positive isolates had the entire operon in the same restriction fragment
after pulsed-field gel electrophoresis, but the isolates were not clonal. Estimation of genetic relatedness
indicated that ica-positive S. epidermidis isolates belonged to different lineages, distributed in only one of
two major clusters, with a genetic distance of c. 0.12.
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INTRODUCTION
Coagulase-negative staphylococci, particularly
Staphylococcus epidermidis, are the most frequent
causes of implanted medical device- or catheter-
related infections, as well as nosocomial bacter-
aemia [1]. Despite the generally low virulence of
S. epidermidis, it is now recognised as a potential
pathogen because of its ability to form biofilms
following primary bacterial attachment to specific
polymeric surfaces, with subsequent multilayered
cluster accumulation or intercellular adhesion.
This multi-step mechanism is considered to be
one of the major factors involved in the patho-
genicity of catheter-related infections caused by
S. epidermidis [2]. Investigation of the second stage
of biofilm formation has demonstrated that cell
aggregation and biofilm accumulation are medi-
ated by the products of the chromosomal ica gene
locus, which comprises four intercellular adhe-
sion genes (icaA, icaB, icaC and icaD) and one
regulator gene (icaR), which seems to function as
a repressor [3–6]. These genes influence the
production of polysaccharide intercellular adhe-
sin (PIA), which is a partially N-acetylated linear
b-1–6-linked glucosaminoglycan. PIA is involved
in haemagglutination [4,7,8] and also acts as an
intercellular adhesin on glass and (probably)
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other hydrophilic surfaces [9]. The role of PIA in
resistance to phagocytosis and other host defence
mechanisms is currently being investigated.
The amount of biofilm production, analysed
phenotypically, is also influenced by changing
environmental conditions, in that stimuli such
as sub-inhibitory concentrations of tetracycline
and quinopristin–dalfopristin, as well as high
temperature, anaerobiosis, ethanol stress and
osmolarity, are known to enhance ica transcrip-
tion and biofilm formation. Complex systems,
such as an alternative sigma factor rB, icaR, an
ethanol-mediating activator of ica operon
expression, or insertion and excision of the
insertion sequence IS256 at specific hot spots
of the icaA and icaC genes, contribute to this
complex regulation system [5,10–12].
The present study analysed 40 epidemiologi-
cally unrelated S. epidermidis isolates, collected
over a 6-month period, in order to determine:
(1) the presence of the icaADBC operon in
S. epidermidis isolates from catheter-related and
other nosocomial infections; (2) the correlation
between the presence of this operon, biofilm
production and resistance to antibiotics; (3) the
expression of ica genes and biofilm production;
and (4) the localisation of the ica operon on the
chromosome and the genetic relatedness of the
isolates.
MATERIALS AND METHODS
Bacterial isolates
The 40 S. epidermidis isolates included in the study were
from catheter-related and other nosocomial infections. Only
isolates for which ‡ 15 CFU were obtained by semiquanti-
tative culture [13,14] were included in the study. Colonisa-
tion was defined as isolation of the same organism from at
least two segments of the catheter or from the tip, with the
latter applying only for patients with a previous history of
sepsis or with a positive blood culture. The isolates were
collected from three Italian laboratories in a 6-month period
during 2000, and were single isolates from different patients
(Table 1). S. epidermidis ATCC 35984 (RP62A) was used as a
positive control for biofilm production, as an ica operon
positive control, and for the amplification probes for the ica
operon.
All isolates were identified with the API-Staph System
(bioMe´rieux, Marcy l’Etoile, France). MICs of oxacillin,
ampicillin, gentamicin, vancomycin, teicoplanin, ciprofloxa-
cin, levofloxacin, co-trimoxazole, erythromycin, tetracycline
and rifampicin were determined according to NCCLS guide-
lines [15]. The methicillin-susceptible S. aureus strain ATCC
29213 was used as a control for antimicrobial susceptibility
tests.
Quantitative and qualitative determination of biofilm
production
Two different methods were used to assay biofilm production:
a spectrophotometric assay (quantitative method), and obser-
vation of slime production (qualitative method). For the
quantitative measurement, each isolate was grown in brain
heart infusion broth and tryptone soya broth (Oxoid, Basing-
stoke, UK), and in a chemically defined medium (CDM),
prepared as described previously [16], except that MgSO4 was
added before the dissolution of the remaining components,
and L-cystine was dissolved in 2–3 drops of 5 M NaOH before
addition to the medium. These assays were performed in
microtitre plates as described previously [6]. Each reported
value was the average of 12 measurements at 490 nm.
Qualitative determination was performed with a Congo Red
agar assay [17]. Agar plates were incubated at 37C for 24 h,
and then for an additional 24 h at room temperature. Black
colonies were considered to be positive variants, while red
colonies were considered to be negative.
PCR
Genomic DNA was isolated from each strain as described
previously [18]. Amplification of the five genes of the ica
operon was by PCR with specific primers (Table 2) designed
from the GenBank published sequence (accession number
U43366). Amplification mixes contained 10 mM Tris-HCl
pH 8.8, 1.5 mM MgCl2, 150 mM KCl, Triton X-100 0.1% v ⁄v,
1 U of Taq polymerase (DyNAzyme II DNA polymerase;
Finnzymes, Oy, Espoo, Finland), 200 lM each dNTP and 1 lL
of genomic DNA. PCR conditions comprised an initial 5-min
denaturation step at 94C, followed by 30 cycles of 1 min at
93C, 30 s at 53C (58C for icaC) and 2 min at 68C, with a
final annealing step of 1 min at 53C (or 58C) and extension
for 10 min at 68C.
For amplification of the entire ica operon, a long PCR was
performed with primers icaR up and icaC down (Table 2).
Amplification was carried out with Takara La Taq polymerase
(BioInc. OTSU, Shiga, Japan), used according to the manufac-
turer’s instructions, with an initial 5-min denaturation step at
94C, followed by 30 cycles of 1 min at 93C, 30 s at 50C and
15 min at 68C, with a final annealing step of 1 min at 50C
and elongation for 10 min at 68C. The predicted amplicon size
was 4013 bp.
DNA sequence analysis
The nucleotide sequences of PCR products were obtained by
the method of Sanger et al. [19]. Sequencing was performed on
a Li-Cor automated sequencing system (Li-Cor Biotechnology,
Lincoln, NE, USA) with infrared dye-labelled sequencing
primers. The sequencing reactions were performed with a
ThermoSequenase fluorescent-labelled primer cycle sequen-
cing kit (Amersham Bioscience, Chalfont St Giles, UK), used
according to the manufacturer’s instructions.
Study of expression
RNA extraction
Cultures were grown in brain heart infusion broth to mid-log
phase, as determined by spectrophotometric growth rate ana-
lysis at 600 nm. Cells were centrifuged at 4000 g for 30 min and
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then resuspended in 200 lL of diethylpyrocarbonate (DEPC)-
treated H2O containing 30 lL of DPEC 0.5% v ⁄v (diluted in
H2O), 100 lL of lysostaphin (50 lg ⁄mL) and 100 lL of lysozyme
(100 lg ⁄mL). After incubation at 37C for 30 min, 1 mL of Trizol
reagent (Gibco BRL, Paisley, UK) was added and incubation was
continued for a further 5 min. Following incubation, 200 lL of
DEPC-treated chloroform was added, and mixed by agitation;
the mixture was incubated for 5 min, and then centrifuged at
10 000 g for 15 min. Following centrifugation, 1 mL of ice-cold
isopropanol was added to the supernatant and the mixture was
incubated at room temperature for 30 min. After centrifugation
at 12 000 g for 15 min, the pellet was resuspended in 50 lL of
DEPC-treated H2O and stored at ) 20C. Genomic DNA was
removed by treatment with RNase-free DNase I (Ambion,
Austin, TX, USA), and the residual RNA concentration was
determined spectrophotometrically. Each extracted RNA sam-
ple was also used as a template in a PCR assay to confirm the
absence of DNA contamination.
RT-PCR
RT-PCR was performed with a two-step procedure in which
c. 200 ng of RNA was added to a mix comprising 50 mM Tris-
HCl, 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol pH 8.3,
200 lM each dNTP, 0.2 lM primers (as described for PCR), and
200 U of M-Mulv reverse transcriptase (BioLabs, Beverly, MA,
USA). cDNA synthesis was performed for 10 min at 58C for
the icaABC genes, and at 54C for the icaRD and pta genes,
followed by incubation at 37C for 20 min. Each RT-PCR assay
amplified the pta gene (a house-keeping gene) as an internal
positive control, with the use of primers described previously
[20].
Pulsed-field gel electrophoresis
Preparation of chromosomal DNA for pulsed-field gel electro-
phoresis (PFGE) was as described previously [21,22]. DNA
was digested with 20 U of SmaI (New England Biolabs,
Beverly, MA, USA) and analysed on a Gene-Navigator
Table 1. Staphylococcus epidermidis
isolates (n = 40) included in the
study
Laboratory
number
Isolate
number Species Hospital
Italian
city Sources
1 1CT S. epidermidis University Polyclinic Catania Catheter tip
2 2CT S. epidermidis University Polyclinic Catania Catheter tip
3 3CT S. epidermidis Vittorio Emanuele Catania Catheter tip
4 4CT S. epidermidis Cannizzaro Catania Catheter tip
5 5CT S. epidermidis University Polyclinic Catania Catheter tip
6 29 CAN S. epidermidis Cannizzaro Catania Catheter tip
7 63 CAN S. epidermidis Cannizzaro Catania Catheter tip
8 82CCH S. epidermidis Ferrarotto Catania Catheter tip
9 86CCH S. epidermidis Ferrarotto Catania Catheter tip
10 1ACLB S. epidermidis Vittorio Emanuele Catania Catheter tip
11 11CLB S. epidermidis Vittorio Emanuele Catania Catheter tip
12 24CLB S. epidermidis Vittorio Emanuele Catania Catheter tip
13 AN3 S. epidermidis Umberto I Ancona Catheter tip
14 AN6 S. epidermidis Umberto I Ancona Catheter tip
15 AN8 S. epidermidis Umberto I Ancona Catheter tip
16 AN10 S. epidermidis Umberto I Ancona Catheter tip
17 RO1 S. epidermidis Gemelli Polyclinic Rome Catheter tip
18 RO3 S. epidermidis Gemelli Polyclinic Rome Catheter tip
19 RO4 S. epidermidis Gemelli Polyclinic Rome Catheter tip
20 RO5 S. epidermidis Gemelli Polyclinic Rome Catheter tip
21 71CCH S. epidermidis Ferrarotto Catania Wound swab
22 75CCH S. epidermidis Ferrarotto Catania Pleural drain
23 80CCH S. epidermidis Ferrarotto Catania Blood
24 6CT S. epidermidis University Polyclinic Catania Bronchial aspirate
25 150D S. epidermidis University Polyclinic Catania Blood
26 RO15 S. epidermidis Gemelli Polyclinic Rome Blood
27 RO16 S. epidermidis Gemelli Polyclinic Rome Blood
28 RO17 S. epidermidis Gemelli Polyclinic Rome Blood
29 3CLB S. epidermidis Vittorio Emanuele Catania Catheter tip
30 4CLB2 S. epidermidis Vittorio Emanuele Catania Catheter tip
31 RO6 S. epidermidis Gemelli Polyclinic Rome Catheter tip
32 RO9 S. epidermidis Gemelli Polyclinic Rome Catheter tip
33 RO10 S. epidermidis Gemelli Polyclinic Rome Catheter tip
34 AN1 S. epidermidis Umberto I Ancona Catheter tip
35 42CAN S. epidermidis Cannizzaro Catania Catheter tip
36 RO19 S. epidermidis Gemelli Polyclinic Rome Blood
37 RO20 S. epidermidis Gemelli Polyclinic Rome Blood
38 163D S. epidermidis University Polyclinic Catania Bronchial aspirate
39 161POL S. epidermidis University Polyclinic Catania Bronchial aspirate
40 19CLB S. epidermidis Vittorio Emanuele Catania Blood
Table 2. Primers and their sequences used in the study
Primer Sequence
Fragment
size (bp) Reference
icaR forwarda 5¢-TACTGTCCTCAATAATCCCGAA 453 This study
icaR reversea 5¢-GGTACGATGGTACTACACTTGATG
icaA forwarda 5¢-TCTCCCCCTTATTCAATTTTCT 1466 This study
icaA reversea 5¢-CGATACAATACATCCAAAATACTC
icaD forwarda 5¢-CAGACAGAGGCAATATCCAAC 225 This study
icaD reversea 5¢-ACAAACAAACTCATCCATCCG
icaB forward 5¢-ATGGCTTAAAGCACACGACGC 526 [6]
icaB reverse 5¢-TATCGGCATCTGGTGTGACAG
icaC forwarda 5¢-ATCATCGTGACACACTTACTAACG 934 This study
icaC reversea 5¢-CTCTCTTAACATCATTCCGACGCC
mecA forward 5¢-GGTCCCATTAACTCTGAAG 1040 [21]
mecA reverse 5¢-AGTTCTGCAGTACCGGATTTTGC
aPrimer designed from published GenBank sequence (accession number U43366).
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apparatus (Pharmacia, Uppsala, Sweden) with the following
PFGE parameters: 20 h at 8C in 0.5 · TBE buffer at 6 V ⁄ cm,
with a forward pulse time of 5 s for 5 h, 10 s for 5 h, 22 s
for 5 h, and 35 s for 5 h. A k-ladder PFGE marker was
included in each run as a molecular size standard. Genetic
relatedness, based on the SmaI PFGE profiles, was calculated
by unweighted pair-group method analysis (UPGMA), with
arithmetic averages based on the Dice coefficient [23–25].
Hybridisation
PFGE fragments were transferred to Hybond N+ nylon
membranes (Amersham Bioscience) with a vacuum blotting
apparatus (Pharmacia), used according to the manufacturer’s
instructions, and were hybridised with three different probes
(the icaA gene, the entire ica locus amplicon, and the mecA
gene) labelled with the non-radioactive ECL system (Amer-
sham Bioscience). The mecA probe was obtained by PCR with
the mecA forward and mecA reverse primers (Table 2) [21]. All
probes were purified with a PCR-product purification kit
(Qiagen, Valencia, CA, USA).
RESULTS
Antibiotic susceptibility
The isolates included in the study were subdi-
vided by PCR into ica-positive and ica-negative
groups. Isolates possessing the ica operon were
more resistant to all classes of antibiotic tested
than were ica-negative isolates. In particular,
there were significant differences in resistance
to oxacillin, gentamicin, ciprofloxacin, levofloxa-
cin, co-trimoxazole and erythromycin (Table 3).
All isolates showed a very high percentage of
resistance to ampicillin and were uniformly
susceptible to vancomycin and teicoplanin.
ica operon organisation; quantitative and
qualitative determination of biofilm production
The presence of the icaADBC genes, including the
regulatory gene icaR, was demonstrated by ampli-
fication of the corresponding fragments in
18 (45%) of 40 isolates. All amplicons were of the
expected sizes, and IS256 insertions were not
detected (Table 4). The ica-positive isolates were
distributed among both catheter-related isolates
(n = 11 isolates) and those from other nosocomial
infections (n = 7). Among the 18 ica-positive iso-
lates, 15 produced a biofilm, as measured by both
methods used in this study, while three isolates
possessing the entire operon were negative for
biofilm production. Qualitative (Congo Red agar
assay) and quantitative determinations of biofilm
production performed in triplicate showed a good
correlation; all strains positive by one test were
also positive by the other (Table 4).
Quantitative spectrophotometric determination
demonstrated that cultural conditions influenced
the production of biofilm (Table 5), and it was
possible to subdivide the isolates growing in
CDM into strong or weak producers, according to
their ability to adhere to the base of the plastic
wells, by measuring the absorbance at 490 nm
[26]. Only the positive control (strain RP62A) had
Table 3. Antibiotic susceptibilities of the Staphylococcus
epidermidis isolates, subdivided with respect to the pres-
ence or absence of the ica operon
Antibiotic
ica-positive strains
18 ⁄ 40 (45%)
ica-negative strains
22 ⁄ 40 (55%) Significance
Oxacillin
Range 1–256 £ 0.25–128
MIC50 32 4
MIC90 128 64
%R 88 45.4 p < 0.05
Gentamicin
Range £ 0.25–256 £ 0.25–128
MIC50 64 0.25
MIC90 128 64
%R 88 31.8 p < 0.001
Ampicillin
Range 256 to > 1024 4 to > 1024
MIC50 1024 1024
MIC90 > 1024 > 1024
%R 100 95.4 NS
Vancomycin
Range 2–8 2–8
MIC50 4 4
MIC90 8 8
%R 0 0
Teicoplanin
Range 1–32 1–32
MIC50 8 8
MIC90 32 16
%R 0 0
Ciprofloxacin
Range 0.12 to > 256 0.12 to > 256
MIC50 8 0.25
MIC90 > 256 16
%R 66.6 18.2 p < 0.01
Levofloxacin
Range 0.12–32 0.12 to > 256
MIC50 2 0.25
MIC90 16 4
%R 38.8 4.5 p < 0.05
Co-trimoxazole
Range £ 0.25–32 £ 0.25–16
MIC50 8 £ 0.25
MIC90 16 0.5
%R 61.1 4.5 p < 0.001
Erythromycin
Range £ 0.12–1024 0.12–1024
MIC50 1024 0.5
MIC90 1024 1024
%R 72.2 27.3 p < 0.05
Tetracycline
Range £ 0.5–128 0.5–64
MIC50 2 0.5
MIC90 4 32
%R 11.1 13.6
Rifampicin
Range £ 0.25 to > 256 £ 0.25–1
MIC50 £ 0.25 £ 0.25
MIC90 > 256 £ 0.25
%R 33.3 0
NS, not significant; R, resistance.
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the same absorbance value for all three media; for
all other isolates, biofilm production was
enhanced in the CDM. Based on the above
criteria, there were 13 strong producers, four
weak producers (with two at the lower limit), and
one negative isolate.
Hybridisation with ica operon and mecA probes
Southern blotting and hybridisation with a probe
for the entire ica operon demonstrated that the
ica operon was localised in the SmaI PFGE
fragment XI in eight (44%) isolates (Fig. 1). The
corresponding PFGE profiles showed that the
isolates did not belong to a single clone (data not
shown). The remaining ten isolates carried the
operon on four different fragments, namely
fragments V (n = 2), X (n = 4), XII (n = 2) and
IX (n = 2). Hybridisation with the mecA probe
showed that 16 of 18 ica-positive isolates carried
the mecA gene, but that this gene was not carried
on the same fragment as the ica operon (data not
shown).
ica operon expression
Expression of icaADBC was studied in ten epi-
demiologically unrelated isolates that were selec-
ted for their different ability to form biofilm
(including the three negative isolates). Only four
isolates showed expression of the icaADBC genes
(Table 6). All biofilm producers expressed icaD;
the icaABC genes were not expressed by the non-
producers (isolates 3, 5 and 8), even though they
were ica-positive by PCR. Co-expression of icaAD
seemed to be necessary for a biofilm-positive
phenotype. The entire operon was sequenced in
these isolates, and no alterations or point muta-
tions were detected.
Genetic relatedness
The 40 isolates clustered into 30 different PFGE
profiles, none of which predominated in the
sample. The results demonstrated the existence
of related PFGE patterns among oxacillin-resist-
ant and ica-positive isolates of S. epidermidis
Table 4. Correlation between the presence of the ica
operon (PCR amplicons; bp) and biofilm production in
brain heart infusion (BHI) broth, as measured with a
spectrophotometric assay (positive cut-off ‡ 0.12 at
490 nm) and slime production on Congo Red agar (CRA)
Isolate Source
PCR fragments (bp)
Biofilm produc-
tion
icaR icaA icaB icaC icaD CRA BHI broth
RP62A 453 1466 526 934 225 + 1.29
1 Catheter 453 1466 526 934 225 + 0.28
2 Catheter None None None None None No NP
3 Catheter 453 1466 526 934 225 No NP*
4 Catheter 453 1466 526 934 225 + 0.12
5 Catheter 453 1466 526 934 225 No NP*
6 Catheter None None None None None No NP
7 Catheter None None None None None No NP
8 Catheter 453 1466 526 934 225 No NP*
9 Catheter 453 1466 526 934 225 + 0.12
10 Catheter 453 1466 526 934 225 + 0.4
11 Catheter None None None None None No NP
12 Catheter None None None None None No NP
13 Catheter 453 1466 526 934 225 + 0.14
14 Catheter None None None None None No NP
15 Catheter None None None None None No NP
16 Catheter None None None None None No NP
17 Catheter None None None None None No NP
18 Catheter None None None None None No NP
19 Catheter 453 1466 526 934 225 + 0.16
20 Catheter None None None None None No NP
21 Other 453 1466 526 934 225 + 0.13
22 Other 453 1466 526 934 225 + 0.13
23 Other 453 1466 526 934 225 + 0.21
24 Other 453 1466 526 934 225 + 0.14
25 Other 453 1466 526 934 225 + 1.12
26 Other None None None None None No NP
27 Other 453 1466 526 934 225 + 0.12
28 Other 453 1466 526 934 225 + 0.20
29 Catheter 453 1466 526 934 225 + 0.16
30 Catheter None None None None None No NP
31 Catheter None None None None None No NP
32 Catheter None None None None None No NP
33 Catheter None None None None None No NP
34 Catheter None None None None None No NP
35 Catheter 453 1466 526 934 225 + 0.6
36 Other None None None None None No NP
37 Other None None None None None No NP
38 Other None None None None None No NP
39 Other None None None None None No NP
40 Other None None None None None No NP
NP*, ica-positive biofilm non-producer; NP, biofilm non-producer.
Table 5. Quantitative determination of biofilm production
under different culture conditions (brain heart infusion
(BHI) broth, tryptone soya broth (TSB) and chemically
defined medium (CDM))
Isolate
Biofilm
production
in BHI
Biofilm
production
in TSB
Biofilm
production
in CDM
RP62A 1.29 1.225 1.78
1 0.28 0.08 1.46
3 0.06 0.10 0.19
4 0.12 0.36 0.67
5 0.07 0.07 0.05
8 0.07 0.10 0.12
9 0.12 0.23 0.36
10 0.4 0.09 0.175
13 0.14 0.08 0.43
19 0.16 0.07 0.25
21 0.13 0.10 0.26
22 0.13 0.10 0.27
23 0.21 0.13 0.65
24 0.14 0.12 0.44
25 1.12 0.22 0.12
27 0.12 0.15 0.59
28 0.20 0.06 0.56
29 0.16 0.07 0.34
35 0.6 0.98 1.34
Isolates were defined as strong biofilm producers (> 0.24), weak biofilm producers
(0.12–0.24) or non-biofilm producers (< 0.12).
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from different sources. The isolates could be
subdivided into two major clusters with a
genetic distance of c. 0.12 (clusters A and B),
with the ica-positive isolates, regardless of whe-
ther they were oxacillin-susceptible or oxacillin-
resistant, and with the sole exception of isolate
29, grouped in cluster A. In contrast, ica-negat-
ive isolates were distributed in the two major
clusters according to whether they were resist-
ant (cluster A) or susceptible (cluster B) to
oxacillin (data not shown).
DISCUSSION
S. epidermidis is a successful coloniser of human
skin and mucous membranes, but neither the
reasons for this success nor the factors respon-
sible for its change from an innocuous saprophyte
to a pathogen are understood precisely. It is
currently the most frequent cause of nosocomial
sepsis and infections of implanted medical
devices, and its pronounced antibiotic resistance
presents a major problem, with a high percentage
of isolates being multiply resistant [27]. Biofilm
formation is considered to be one of the main
virulence factors [28], as the most important
infections caused by this microorganism are
infections involving foreign bodies. Several stud-
ies have shown that the ica gene locus is always
present in sepsis-causing isolates, but is not
detectable in saprophytic isolates [28–30]. Biofilm
formation in staphylococci is multifactorial, and
the ability to form biofilm enhances the ability of
strains to survive in normally hostile environ-
ments.
In the present study, 45% of S. epidermidis
isolates from catheter-related and other nosoco-
mial infections were ica-positive. The ica-positive
isolates were also more resistant to antibiotics,
thus confirming previous observations [30]. There
was a strong association between the presence of
the ica operon and the presence of the mecA gene
(16 of 18 isolates), and consequently, with a
multiply resistant profile. These results support
the idea that the ica and mecA genes can be
considered as important virulence markers for
clinically significant staphylococcal isolates; the
expression of both gene clusters confers an
enhanced survival ability and favours the onset
of chronic infections, such as those associated
with implanted medical devices. All of the iso-
lates included in the study originated from single
or mixed infections, and are probably able to
produce adhesins for the host matrix proteins that
are adsorbed in vivo on to the surface of bioma-
terials [31–34].
The presence of the entire icaADBC gene
cluster, including the regulatory gene icaR, was
Fig. 1. Southern blot of SmaI PFGE fragments from differ-
ent Staphylococcus epidermidis isolates following hybridisa-
tion with a probe for the ica operon.
Table 6. RT-PCR amplicons (bp) of the icaABCD genes
produced from a representative sample of ten Staphylococ-
cus epidermidis isolates
Isolate
Amplicons (bp)
icaA icaB icaC icaD
1 1466 526 None 225
3 None None None 225
4 1466 526 934 225
5 None None None 225
8 None None None 225
10 1466 526 934 225
13 1466 526 934 225
21 1466 526 934 225
24 1466 None None 225
25 1466 526 934 225
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confirmed by PCR and Southern blot analysis in
18 isolates, but only 15 of these were considered
to produce biofilm. In agreement with the results
of other studies, biofilm production was highly
influenced by cultural conditions, with the pres-
ence of glucose 1% w ⁄v in a CDM enhancing the
production of biofilm in almost all isolates. All ica-
negative isolates failed to produce biofilm under
the conditions tested in this study, but two of the
three ica-positive non-biofilm producers became
producers in CDM. Southern blot analysis dem-
onstrated that the ica operon was generally
present on the same PFGE fragment (unlinked
to the mecA gene) in different isolates, but PFGE
analysis showed that most of the isolates
belonged to different strains.
Expression of the icaADBC operon is essential
for the synthesis of polysaccharide intercellular
adhesin, which mediates cell-to-cell adhesion and
promotes a biofilm-positive phenotype for S. epi-
dermidis. The present study analysed the tran-
scriptional activity of ica genes in a sample of
biofilm-positive and -negative isolates, and dem-
onstrated that icaD was always expressed, but
that biofilm production occurred only when icaA
was also expressed. The reasons for the absence of
biofilm production in some isolates, despite the
presence of the entire ica operon, and the lack of
transcription of the icaC gene in some isolates,
considered necessary for PIA elongation, remain
unclear. Only one promoter, located upstream of
the icaA gene, has been mapped in the entire
operon [6], and the possibility of sequence alter-
ations and point mutations, perhaps causing loss
of function of downstream cistrons, was excluded
in these isolates.
In view of these findings, two different hypo-
theses can be proposed: (1) the overlap of both
icaA ⁄D and icaB ⁄C, together with the observation
that the corresponding proteins are encoded by
different frames of the same nucleotide sequence,
could support the idea of a regulatory mechanism
that controls the simultaneous transcription of
mRNA from the different ica genes; or (2) the icaR
gene product, together with changes in environ-
mental conditions, could influence transcription
of the ica operon. The present study demonstrated
that the presence of the entire cluster did not
always correlate with biofilm production, but
there was an indication that such a correlation
may occur when at least two genes (icaAD) were
co-transcribed.
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